2020年毕业于武汉大学化学与分子科学学院，硕博期间在武汉大学生物医用高分子材料教育部重点实验室从事科研工作，师从张先正教授。主要从事生物医用材料、药物递送系统、生物医用纳米材料等领域的研究。近年来，以第一作者和共同第一作者在Science Advances，Nature Communications，Advanced Materials，Chemical Science，Small等国际著名期刊上发表SCI论文7篇。
电子邮箱
hongsh25@mail.sysu.edu.cn; hongs@whu.edu.cn
学科专业
药剂学
个人经历
2011.09-2015.07，武汉大学，化学，学士
2015.09-2017.07，武汉大学，化学，硕士
2017.09-2021.02，武汉大学，化学，博士
2021.06至今，中山大学，药学院（深圳），助理教授
研究方向
生物医用材料、纳米医学、药物控释
代表论著
1. Hong Sheng, Zheng Di-Wei, Zhang Cheng, Huang Qian-Xiao, Cheng Si-Xue, Zhang Xian-Zheng*. Vascular Disrupting Agent Induced Aggregation of Gold Nanoparticles for Photothermally Enhanced Tumor Vascular Disruption. Science Advances 2020, 6, eabb0020. ( IF: 14.136)
2. Hong Sheng#, Zheng Di-Wei#, Zhang Qiu-Ling, Deng Wei-Wei, Song Wen-Fang, Cheng Si-Xue, Sun Zhi-Jun, Zhang Xian-Zheng* An RGB-Emitting Molecular Cocktail for the Detection of Microbiota Fingerprints. Chemical Science 2020, 11, 4403-4409. (IF: 9.825)
3. Hong Sheng, Zhang Qiu-Ling, Zheng Di-Wei, Zhang Cheng, Zhang Yu, Ye Jing-Jie, Cheng Han, Zhang Xian-Zheng*. Enzyme Mimicking Based on Natural Melanin Particles from Human Hair. iScience 2020, 23, 100778. (IF: 5.458)
4. Zheng Di-Wei#, Hong Sheng# (共一), Xu Lu, Li Chu-Xin, Li Ke, Cheng Si-Xue, Zhang Xian-Zheng*. Hierarchical Micro-/Nanostructures from Human Hair for Biomedical Applications. Advanced Materials 2018, 30, 1800836. (IF: 30.849)
5. Zheng Di-Wei#, Hong Sheng# (共一), Zhang Qiu-Ling, Dong Xue, Pan Pei, Song Wen-Fang, Song Wen, Cheng Si-Xue, Zhang Xian-Zheng*. Controllable gelation of artificial extracellular matrix for altering mass transport and improving cancer therapies. Nature Communications 2020, 11, 4907. (IF: 14.919)
6. Dong Cheng-Yuan#, Hong Sheng#(共一), Zheng Di-Wei, Huang Qian-Xiao, Liu Fu-Sheng*, Zhong Zhen-Lin*, Zhang Xian-Zheng*. Multi-functionalized Gold Sub-Nanometre Particles for Sensitizing Radiotherapy against Glioblastoma. Small 2021, 17, 2006582. (IF: 13.281)
7. Hong Sheng, Huang Qian-Xiao, Zhong Zhenlin, Rong Lei, Zhang Xian-Zheng*. Photo-Initiated Coagulation Activation and Fibrinolysis Inhibition for Synergetic Tumor Vascular Infarction. CCS Chemistry 2021, 3, 1893–1910.
